Doped Biomolecules in Miniaturized Electric Junctions - American

Apr 26, 2012 - center that inverts affinity upon guest incorporation and thus controls the ... applications, aiming at doping of nanoscale electric ju...
0 downloads 0 Views 4MB Size
Article pubs.acs.org/JACS

Doped Biomolecules in Miniaturized Electric Junctions Elad Mentovich,†,‡ Bogdan Belgorodsky,‡ Michael Gozin,‡ Shachar Richter,*,†,§ and Hagai Cohen*,∥ †

Center for Nanoscience and Nanotechnology, ‡School of Chemistry, and §Faculty of Exact Sciences, Tel-Aviv University, P.O. Box 39040, Tel-Aviv 69978, Israel ∥ Department of Chemical Research Support, Weizmann Institute of Science, Rehovot 76100, Israel S Supporting Information *

ABSTRACT: Control over molecular scale electrical properties within nano junctions is demonstrated, utilizing site-directed C60 targeting into protein macromolecules as a doping means. The protein molecules, selfassembled in a miniaturized transistor device, yield robust and reproducible operation. Their device signal is dominated by an active center that inverts affinity upon guest incorporation and thus controls the properties of the entire macromolecule. We show how the leading routes of electron transport can be drawn, spatially and energetically, on the molecular level and, in particular, how the dopant effect is dictated by its “strategic” binding site. Our findings propose the extension of microelectronic methodologies to the nanometer scale and further present a promising platform for ex situ studies of biochemical processes.

E

the same size as the original BSA protein. The C60 buckyball has already been shown to bind selectively to an albumin site at subdomain IIA,27 close to the Trp214 tryptophan site.28 Selfassembly on gold resulted in rather uniform BSA monolayers, ∼4 nm thick, with a slightly more “open” conformation (less compact organization) of the doped-BSA (see the Supporting Information for synthesis, purification, and characterization details). Direct transport measurements were performed in a C-Gate MolVet device20(Figure 1, bottom left), recording the current/ voltage characteristics through the molecular layer, between source and drain electrodes, ISD/VSD, while modulating the field via a third, central gate electrode (VG). This type of devices offers very high sensitivity at relatively low VSD and VG regimes, thus allowing efficient and nondestructive scanning of sample’s molecular orbitals.22,29 Figure 2 top compares representative ISD/VSD characteristics of the doped and undoped BSA-based junctions, measured at 77 K. In both cases, the gate effect under positive VSD is negligible, in contrast to the negative VSD regime. At negative polarity of the C60−BSA transistor, current values are considerably lower than those of the undoped device, while similar current magnitudes are obtained for positive VSD. As was already discussed previously,20 Fowler−Nordheim tunnelling (FN) dominates the low-field negative VSD region. At the high-field regime, the curves obey J ∝ Fα, pointing at charge limited (CL) mechanisms,30 where α is the CL exponent. The critical field, at which CL begins to dominate over FN, is higher by ∼250 mV in the C60−BSA complex, as compared to the undoped protein (see also Supporting Information). Figure 2 bottom further shows that α is highly gate-dependent in the undoped BSA, suggesting a significant

xtensive efforts are continuously devoted to the understanding and development of soft matter electronics1−4 toward using organic molecules as flexible building blocks in dense architectures.5,6 The need for fine-control over their optical and electrical properties, via doping,7,8 for example, presents a major challenge, because statistical dopant distribution is applicable only to components much larger than the average distance between neighboring dopants.9,10 Alternative approaches are therefore needed; for example, by directing dopant species to preselected sites of the host matrix. In this respect, macromolecules11−14 and solid-state biomolecules in particular15−17 offer useful advantages. Upon hosting foreign species, fine changes in the macromolecule properties can potentially be achieved with minimal effect on their structural and assembly characteristics. Nature often utilizes the binding of small molecules at host sites; for example, in the transport of hydrophobic molecules through lipid-binding protein complexes,18 and of fatty acids by albumins.19 Here, we exploit this feature for electronic applications, aiming at doping of nanoscale electric junctions and transistors. The electrical properties of the system are explored utilizing a nanometer-scale Central Gate Vertical Molecular Transistor20−22 (C-Gate MolVeT, Figure 1, bottom left) and a contactless technique, Chemically Resolved Electrical Measurements (CREM, Figure 1, bottom right),23−26 which can resolve the local potential at selected chemical addresses. Intriguing details of the electrical transport across the macromolecule and, specifically, the role of the C60 guest in switching the molecule electrical affinity are thus revealed. A simple synthetic methodology was used to get site-specific targeting of C60 molecules into self-assembled monolayers (SAM) of Bovine Serum Albumin (BSA) protein (Figure 1, top).27 BSA−C60 is a well-defined complex, with approximately © 2012 American Chemical Society

Received: December 18, 2011 Published: April 26, 2012 8468

dx.doi.org/10.1021/ja211790u | J. Am. Chem. Soc. 2012, 134, 8468−8473

Journal of the American Chemical Society

Article

Figure 1. Top: Schematic illustration of the undoped (left) and C60-doped (right) BSA. Bottom left: A simplified cartoon of the C-Gate MolVet structure. The vertical transistor is formed inside a microcavity: source (Au, I), drain (Pd, II), and gate (Ti−TiO2, III) electrodes that are used to activate the protein monolayer (IV). The microcavity is bordered by Si3N4 (V), and the gate electrode is activated by highly doped silicon/silicon oxide layer (VI). Bottom right: The CREM setup. Input signals are the X-ray irradiation, the eFG low-energy electrons, and the sample bias. Output signals are the photoelectron spectrum and the sample current (see the Supporting Information for details).

Figure 2. Transistor transport data. Top: ISD/VSD of the undoped (left) and the doped-BSA (right) device, as a function of VG. Main panels (insets) show I−V curves recorded under negative (positive) VSD. Note how the current magnitude increases (decreases) under negative (positive) polarity as VG is increased (VG step size = 0.05 V), pointing at electron (hole) dominated transport mechanisms. Bottom: Variation of the negative-polarity exponent factor (α) with VG (left) in BSA (■) and C60-BSA (●), as derived from the log−log I−V plots on the right. 8469

dx.doi.org/10.1021/ja211790u | J. Am. Chem. Soc. 2012, 134, 8468−8473

Journal of the American Chemical Society

Article

Figure 3. Element-specific CREM data: (a) Surface potential (ΔV) versus sample bias (VB) characteristics of undoped 40 Å thick BSA monolayer on gold. Scan direction is given by the arrows. Two regimes are distinguished: (I) positive charging and (II) negative charging. (b) The corresponding current−voltage I−ΔV curves. (c) The C60-BSA ΔV−VB curves. (d) A summary of potential variations under positive (P) and negative (N) charging conditions; the electrostatic irreversibility (D, drift) along the first scan; the work-function of the fresh surface, shifted by −4 eV (WF). Note the reduced resistance and increased hysteresis in the doped system. The experimental error in ΔV is 5, 40, 50, and 70 mV for the Au, C, O, and N, respectively. Color coding for the four elements is given in the inset to (a).

energy distribution of charge trap levels within the layer.31 On the other hand, the doped junction exhibits identical slopes, α ≈ 2, which points to the leading role of a dominant trap energy (Figure 2 bottom),30,31 similar to reports on conjugatedpolymer devices.31 From the ISD/VG dependence, one learns that under negative polarity the conduction is electron dominated (current increasing with VG), while for positive polarity it is dominated by hole transport (current decreasing upon VG increase). A complementing view on the studied systems is provided by the element-specific chemically resolved electrical measurements (CREM) curves, Figure 3a−c, recorded from monolayers on gold substrates with no top contacts. The experiment utilizes photoelectrons to read electrostatic potentials from selected atomic sites.23 It is conducted at room temperature, exposing the sample to a flux of slow ( 0.32 (II) A low negative bias range, where eFG electrons are injected to the sample and negative surface charge (Q < 0) is accumulated. The crossover between the two regimes, given by an inflection point (IP), was shown to define the work-function (WF) of the sample.33 Notably, significant ΔV values develop at the bare BSA, tending to saturate at high currents (low negative VB) and undergoing hysteresis under decreasing the current back to low values. These features are common to all overlayer signals.

Differences between the elemental curves in Figure 3a,b reflect affinity variations34 and, in particular, enhanced mean affinity of the N sites to injected electrons and of the O sites to positive charge, to be discussed elsewhere. Note that the Au line-shifts determine the full back-contact impedance to be eliminated from the overlayer data. The C60−BSA curves in Figure 3c manifest a marked doping effect: (1) enhanced positive charging; (2) reduced negative charging; and (3) remarkably asymmetric hysteresis: large irreversibility in all elemental curves in region I, while in region II all curves are fully reversible (no hysteresis). Thus, the C60 molecules, known to be very good electron acceptors,35 do not tend to capture the injected electrons (no hysteresis in II). On the contrary, hole trapping becomes of very long lifetime characteristics (pronounced hysteresis in I). Average potential variations and the overall irreversibility (electrostatic drift) are summarized in Figure 3d. To understand this striking result, note first that a ∼350 meV difference in work function (WF) is extracted from the inflection points (between regions I and II) in Figures 3a,c, yielding WF = 4.35 and 4.7 eV for the bare and the doped BSA, respectively. This WF change is associated with extended charge redistribution upon C60 complexation (see discussion below), where the C60 site becomes electron rich and a good donor, in agreement with the pronounced positive charging in Figure 3c. Second, both WF values are considerably smaller than those of bare Au and Pd surfaces (∼5.0 eV); hence, interface dipoles at the electrode contacts must be considered, both acting against electron conduction. Despite these dipoles, dominant electron conduction is measured under negative polarity, which highlights the intrinsic medium property: highly favored electron transport. The interface dipoles necessarily differ in width (see Figure 4a), a fact inferred from the rectification in Figure 2 (see also the Supporting Information 8470

dx.doi.org/10.1021/ja211790u | J. Am. Chem. Soc. 2012, 134, 8468−8473

Journal of the American Chemical Society

Article

indeed, the hole conductance (under positive polarity) is negligibly affected by the dopant, as expected from the proposed mechanism. Identification of the leading conduction routes in the BSA macromolecule is an important outcome of this work. Figure 4c further reveals another interesting feature: a broad spatial distribution of donor groups that collectively take part in charge donation to the C60 site during complexation. Contribution from distant tyrosine groups, including groups located close to the Au substrate, is essential for explaining the experimentally observed dipole sign and magnitude. In fact, the magnitude of the molecular dipole should be self-limited by the presence of acceptor states that can gain charge as soon as the intramolecular potential drop exceeds T2−T1 (Figure 4a), which is in good agreement with our measurements (∼350 meV). This very charge transfer further explains the inefficient discharge of holes from the C60 site, manifested by Figure 3c. First, it creates a molecular dipole that acts against hole discharge to the gold, and, second, the leading candidate sites for hole-hopping are partially blocked (“emptied” from electrons). Our results imply on the potential suitability of biological molecules to future electronic devices, exhibiting both stability and useful functionality. The inspected BSA layers are relatively very robust, far better than, for example, alkane chain monolayers,10,25 retaining reproducible and well-behaving appearance in the transistor device (up to a year for VSD < 2 V; see the Supporting Information for more details) and, to a lesser extent, under long X-ray irradiation. This may originate in their dry condensed phase, as opposed to aqueous environment in biological systems, where degradation is accelerated.11,12,38 The recognition capabilities of biological molecules present another useful feature: BSA can absorb foreign species with minor influence on its assembly characteristics and yet with a marked impact on electrical properties. The present usage of recognition is very different from the self-wiring applications proposed for DNA.39,40 It is aimed at novel doping-like variability in molecule properties, playing with the host−guest combination and their associated binding site. The observed switch in molecule affinity is essentially the function of an active center, here responsible for the behavior of a macro molecule. Can one learn from these experiments on biological mechanisms involving binding and release of small molecules?41,42 The conditions here do not quite imitate the aqueous biological environment, and, obviously, the C60 molecule is not released here from its host. Yet, one does succeed in these experiments to controllably deviate from charge neutrality and follow the site-selective charge transfer mechanisms. Thus, the present methodology proposes a unique view on molecular level chemical activity, which may be proven useful in studies of biochemical mechanisms. In summary, we have demonstrated a new approach to doping-like electrical control suited for the molecular scale and inspected its function by complementing nanoscale-sensitive electrical probes. Using biological molecules embedded in a solid-state transistor, we exploited the C60 recognition at a specific protein domain for achieving accurate, site-directed modifier of the monolayer dielectric properties. We have shown how the manipulated protein site can switch between an acceptor and a donor state, obeying external stimuli for charge neutrality violation, and how detailed understanding of the leading conduction paths can be gained at the submolecular level. The present approach can be exploited for the

Figure 4. The transport mechanism: (a) A schematic description of energy levels under negative bias conditions; hole injection from the top Pd contact and electron injection from the gold substrate are indicated. Acceptor trap states in the range T1−T2 (∼350 meV wide) dominate the charge transport; their position relative to the electrodes’ EF is affected by VG, as illustrated at the bottom scheme. The interface barrier height, ∼700 meV, is shown at the Au interface. Note that the C60 dopant blocks T1 levels; see bottom illustration. (b) A corresponding scheme under the eFG electron injection in CREM. (c) The BSA molecular structure with its leading acceptor (phenylalanine, light blue) and donor (tyrosine, red) sites. The C60 (violet), the tryptophan sites (green), and the cysteine binding group (yellow) are also indicated. A 3D movie presentation of the molecule is provided in the Supporting Information.

for bare BSA data), such that under positive polarity, the thicker barrier at the Pd side (note the absence of direct BSA− Pd chemical bond) leads to hole-dominated transport. The CL transport dynamics in bare BSA likely involves plural trap energies, leading to high exponent values α ≫ 2.36 Figure 2 shows however that α decreases rapidly (→2) for increased VG, indicating that the corresponding energy width is limited, on the scale of 350 meV, as illustrated by T1 and T2 in Figure 4a. Our results further suggest that upon complexation with C60, critical T1 sites transform from acceptors to strong donors and, thus, block electron conduction. This process is expressed (see Figure 2) in (1) a drastic current suppression; (2) a strict α ≈ 2 exponent value; and (3) a shift of the crossover voltage between the FN and CL regimes. Accordingly, the doping effect becomes negligible under positive polarity, when hole transport dominates, which fully agrees with our argument on selective inactivation of acceptor-type hopping routes. The above results can be better understood in light of the 3D molecular structure (see movie, Supporting Information). Figure 4c shows a 2D projection of the BSA molecule with its leading acceptor (phenyl, light blue) and donor (tyrosine, red) groups.37 Recalling that the empty (no C60) subdomain IIA presents a strong acceptor site (tryptophan, Trp214) and that the CL conduction of electrons is carried by acceptors, an injected electron can easily complete a continuous hopping path (upward, through phenyl groups, blue) in the undoped case. However, as soon as the central Trp site turns to be a donor, the favored electron-hopping paths are blocked. Notably, it is not just the C60 character but also its critical “bottleneck” location that dictates the electrical behavior, and, 8471

dx.doi.org/10.1021/ja211790u | J. Am. Chem. Soc. 2012, 134, 8468−8473

Journal of the American Chemical Society



development of improved sensors and nanoscale devices and, possibly, for studies of complex electron transfer mechanisms in biological systems.



Article

ASSOCIATED CONTENT

S Supporting Information *

(1) A note regarding doping at the nanometer scale; (2) complementing aspects of the present electrical probes; (3) technical comments on the CREM study; (4) layer characterization; (5) protein structure calculation method; (6) information on the device performance; and (7) a 3D movie presentation of BSA. This material is available free of charge via the Internet at http://pubs.acs.org.

MATERIALS AND METHODS

C-Gate MolVet Fabrication. A network of gold electrodes was defined on top of a highly doped silicon wafer covered with 100 nm thick thermal oxide, followed by the deposition of a 70 nm layer of Si3N4 dielectric material. Next, arrays of microcavities, ranging from 800 nm to 1.5 μm in diameter, were created by drilling holes via reactive ion etcher (RIE) through the entire layer down to the highly doped silicon substrate, followed by mild wet etching of several nanometers of the gold electrode. This undercut in the electrode provided space for oxide growth. This step was followed by the evaporation of a titanium column, a photolithography shape definition of the larger cavity, and oxidation of the titanium column that formed the gate electrode. Self-assembly of the protein-based monolayer on top of the exposed gold ring was then performed, followed by shape definition of the upper electrode and indirect or chopper evaporation of palladium on top of the protein layer. Measurements were performed using a cryogenic probe station equipped with a semiconductor parameter analyzer (Keithley 4200 SCS). See the Supporting Information for repeatability and performance characterization. Materials. Essential fatty acids and globulin free BSA, fine chemicals, and solvents were purchased from Sigma−Aldrich. C60− fullerene was purchased from Sesres, and γ-CD2C60 was synthesized according to previously reported methods.43 BSA−C60 Complex Preparation. A 50 μM solution of BSA in tris-acetate buffer (20 μM, pH 7.2) was incubated with 2 equiv of γCD2C60 at 10 °C for 24 h. The complexation solution was separated and purified on a Sephadex G-25 gel-permeation column (Pharmacia Biotech) with tris-acetate buffer (20 mM, pH 7.2) or on an HPLC TSK-GEL column. An optimized stepwise, removal−addition procedure included incubating BSA and γ-CD2C60 at 10 °C for 48 h at a 1:2 molar ratio in tris-acetate buffer (20 mM, pH 7.2), followed by the removal of γ-CD−fullerene clusters and γ-CD by size-exclusion chromatography (Pharmacia, G25 cartridge, 20 mM tris-acetate buffer, pH 7.2), and subsequent addition of 2 equiv of γ-CD2C60 to a BSAcontaining fraction. This procedure was repeated six times, once every 48 h. The buffer concentration was reduced by reloading the complexcontaining fraction on a second Sephadex G-25 column and eluting the complex with a tris-acetate buffer (1.0 mM, pH 7.2). The resulting complex solution was lyophilized for storage and further experiments. After reconstitution in water, the complex concentration in solution was determined by UV−visible spectroscopy and a BioRad protein assay (Bio-Rad Lab). CREM (Chemically Resolved Electrical Measurements). The XPS-based electrical measurements were performed on a slightly modified Kratos AXIS-HS setup, using a monochromatic X-ray source, Al Kα, at low power, 75 W, and base pressure of 1 × 10−9 Torr. The eFG was operated at 1.8 A filament current and −2.5 V grid bias. A Keithley 487 electrometer was connected to the sample back contact, providing both current detection and sample biasing. For reliable extraction of the layer dielectric response, reversible line-shifts were differentiated from any irreversible electrostatic (and chemical) modifications. A detailed follow-up of the beam-induced changes was further conducted (see the Supporting Information) such as to extract the degradation information on a broad range of time scales. Rapid CREM-based WF measurements were performed initially, before exposure to any irradiation, and later again, both on fresh and on irradiated spots at sequencing stages of the experiment. (Early electrostatic changes could frequently be identified, but soon the electrical data stabilized, and also no significant changes in the standard (XPS) chemical analysis were observed, indicating high stability of the system.) The error in ΔV determination can approach ≤5 mV, but for the noisy signals we achieved 30−70 mV.



AUTHOR INFORMATION

Corresponding Author

[email protected]; [email protected] Notes

The authors declare no competing financial interest.

■ ■

ACKNOWLEDGMENTS This research was supported by the Israeli Science Foundation, project no. 604, and the USAF. REFERENCES

(1) Smits, E. C. P.; Mathijssen, S. G. J.; van Hal, P. A.; Setayesh, S.; Geuns, T. C. T.; Mutsaers, K. A. H. A.; Cantatore, E.; Wondergem, H. J.; Werzer, O.; Resel, R.; Kemerink, M.; Kirchmeyer, S.; Muzafarov, A. M.; Ponomarenko, S. A.; de Boer, B.; Blom, P. W. M.; de Leeuw, D. M. Nature 2008, 455, 956−959. (2) Akkerman, H. B.; Blom, P. W. M.; de Leeuw, D. M.; de Boer, B. Nature 2006, 441, 69−72. (3) Galperin, M.; Ratner, M. A.; Nitzan, A.; Troisi, A. Science 2008, 319, 1056−1060. (4) Del Nero, J.; de Souza, F. M.; Capaz, R. B. J. Comput. Theor. Nanosci. 2010, 7 (3), 503−516. (5) Joachim, C.; Ratner, M. A. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 8801−8808. (6) Green, J. E.; Choi, J. W.; Boukai, A.; Bunimovich, Y.; JohnstonHalperin, E.; DeIonno, E.; Luo, Y.; Sheriff, B. A.; Xu, K.; Shin, Y. S.; Tseng, H. R.; Stoddart, J. F.; Heath, J. R. Nature 2007, 445, 414−417. (7) Sung, C. F.; Kekuda, D.; Chu, L. F.; Lee, Y. Z.; Chen, F. C.; Wu, M. C.; Chu, C. W. Adv. Mater. 2009, 21, 4845−4849. (8) Ho, J. C.; Yerushalmi, R.; Jacobson, Z. A.; Fan, Z.; Alley, R. L.; Javey, A. Nat. Mater. 2008, 7, 62−67. (9) Hayden, O.; Bjork, M. T.; Schmid, H.; Riel, H.; Drechsler, U.; Karg, S. F.; Lortscher, E.; Riess, W. Small 2007, 3, 230−234. (10) Seitz, O.; Vilan, A.; Cohen, H.; Hwang, J.; Haeming, M.; Schoell, A.; Umbach, E.; Kahn, A.; Cahen, D. Adv. Funct. Mater. 2008, 18, 2102−2113. (11) Bramanti, A.; Pompa, P. P.; Maruccio, G.; Calabi, F.; Arima, V.; Cingolani, R.; Corni, S.; Di Felice, R.; De Rienzo, F.; Rinaldi, R. Jpn. J. Appl. Phys., Part 1 2005, 44, 6864−6866. (12) Maruccio, G.; Biasco, A.; Visconti, P.; Bramanti, A.; Pompa, P. P.; Calabi, F.; Cingolani, R.; Rinaldi, R.; Corni, S.; Di Felice, R.; Molinari, E.; Verbeet, M. R.; Canters, G. W. Adv. Mater. 2005, 17, 816. (13) Medalsy, I.; Dgany, O.; Sowwan, M.; Cohen, H.; Yukashevska, A.; Wolf, S. G.; Wolf, A.; Koster, A.; Almog, O.; Marton, I.; Pouny, Y.; Altman, A.; Hoseyov, O. S.; Porath, D. Nano Lett. 2008, 8, 473−477. (14) Chi, Q. J.; Farver, O.; Ulstrup, J. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 16203−16208. (15) Cahen, D.; Ron, I.; Pecht, I.; Sheves, M. Acc. Chem. Res. 2010, 43, 945−953. (16) Davis, J.; Peters, B.; Xi, W.; Axford, D. Curr. Nanosci. 2008, 4, 62−70. (17) Shinwari, M. W.; Deen, M. J.; Starikov, E. B.; Cuniberti, G. Adv. Funct. Mater. 2010, 20, 1865−1883. (18) Banaszak, L.; Bernlohr, D. Mol. Cell. Biochem. 1999, 192, 1-1. (19) Peters, T. J. All About Albumin: Biochemistry, Genetics, and Medical Applications; Academic: San Diego, CA, 1995; p 414. 8472

dx.doi.org/10.1021/ja211790u | J. Am. Chem. Soc. 2012, 134, 8468−8473

Journal of the American Chemical Society

Article

(20) Mentovich, E.; Belgorodsky, B.; Kalifa, I.; Cohen, H.; Richter, S. Nano Lett. 2009, 9, 1296−1300. (21) Mentovich, E. D.; Belgorodsky, B.; Kalifa, I.; Richter, S. Adv. Mater. 2010, 22, 2182−2186. (22) Mentovich, E. D.; Belgorodsky, B.; Richter, S. J. Phys. Chem. Lett. 2011, 2, 1125−1128. (23) Cohen, H. Appl. Phys. Lett. 2004, 85, 1271−1273. (24) Rozenblat, A.; Rosenwaks, Y.; Cohen, H. Appl. Phys. Lett. 2009, 94, 213501. (25) Cohen, H.; Maoz, R.; Sagiv, J. Nano Lett. 2006, 6, 2462−2466. (26) Doron-Mor, H.; Hatzor, A.; Vaskevich, A.; van der Boom-Moav, T.; Shanzer, A.; Rubinstein, I.; Cohen, H. Nature 2000, 406, 382−385. (27) Belgorodsky, B.; Fadeev, L.; Kolsenik, J.; Gozin, M. ChemBioChem 2006, 7, 1783−1789. (28) Belgorodsky, B.; Fadeev, L.; Ittah, V.; Benyamini, H.; Zelner, S.; Huppert, D.; Kotlyar, A. B.; Gozin, M. Bioconjugate Chem. 2005, 16, 1058−1062. (29) Mentovich, E. D.; Rosenberg-Shraga, N.; Kalifa, I.; Tsukernik, A.; Hendler, N.; Gozin, M.; Richter, S. J. Nanosci. Nanotechnol. 2010, 10, 8260−8264. (30) Blom, P. W. M.; deJong, M. J. M.; Vleggaar, J. J. M. Appl. Phys. Lett. 1996, 68 (23), 3308−3310. (31) Shen, J.; Yang, J. J. Appl. Phys. 1998, 83, 7706−7714. (32) The CREM-derived potentials are defined here to be positive for negative charge accumulation, consistent with previous CREM works. (33) Cohen, H.; Nogues, C.; Zon, I.; Lubomirsky, I. J. Appl. Phys. 2005, 97, 113701. (34) Cohen, H.; Zenkina, O. V.; Shukla, A. D.; van der Boom, M. E. J. Phys. Chem. B 2006, 110, 1506−1508. (35) Guldi, D. M.; Illescas, B. M.; Atienza, C. M.; Wielopolskia, M.; Martin, N. Chem. Soc. Rev. 2009, 38, 1587−1597. (36) Burrows, P. E.; Shen, Z.; Bulovic, V.; McCarty, D. M.; Forrest, S. R.; Cronin, J. A.; Thompson, M. E. J. Appl. Phys. 1996, 79, 7991− 8006. (37) Gao, J. A.; Muller, P.; Wang, M.; Eckhardt, S.; Lauz, M.; Fromm, K. M.; Giese, B. Angew. Chem., Int. Ed. 2011, 50, 1926−1930. (38) Pompa, P. P.; Bramanti, A.; Maruccio, G.; del Mercato, L. L.; Cingolani, R.; Rinaldi, R. Chem. Phys. Lett. 2005, 404, 59−62. (39) Braun, E.; Eichen, Y.; Sivan, U.; Ben-Yoseph, G. Nature 1998, 391, 775−778. (40) Keren, K.; Krueger, M.; Gilad, R.; Ben-Yoseph, G.; Sivan, U.; Braun, E. Science 2002, 297, 72−75. (41) Varshney, A.; Sen, P.; Ahmad, E.; Rehan, M.; Subbarao, N.; Khan, R. H. Chirality 2010, 22, 77−87. (42) Kratz, F. J. Controlled Release 2008, 132, 171−183. (43) Buvari-Barcza, A.; Rohonczy, J.; Rozlosnik, N.; Gilanyi, T.; Szabo, B.; Lovas, G.; Braun, T.; Samu, J.; Barcza, L. J. Chem. Soc., Perkin Trans. 2 2001, 191−196.

8473

dx.doi.org/10.1021/ja211790u | J. Am. Chem. Soc. 2012, 134, 8468−8473